Liquidia Corporation $LQDA Shares Purchased by WCG Wealth Advisors LLC

WCG Wealth Advisors LLC increased its holdings in shares of Liquidia Corporation (NASDAQ:LQDA) by 98.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 54,411 shares of the company’s stock after buying an additional 26,957 shares during the period. WCG Wealth Advisors LLC’s holdings in Liquidia were worth $1,877,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Liquidia by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after acquiring an additional 1,700 shares during the period. Goldman Sachs Group Inc. raised its stake in Liquidia by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock worth $12,703,000 after acquiring an additional 82,955 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after acquiring an additional 16,022 shares during the period. Creative Planning raised its stake in Liquidia by 40.7% during the second quarter. Creative Planning now owns 26,840 shares of the company’s stock worth $334,000 after acquiring an additional 7,765 shares during the period. Finally, Legal & General Group Plc raised its stake in Liquidia by 13.4% during the second quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock worth $1,174,000 after acquiring an additional 11,111 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on LQDA shares. Lifesci Capital upgraded shares of Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. HC Wainwright upped their target price on shares of Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday. Wall Street Zen upgraded shares of Liquidia from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 16th. Oppenheimer set a $75.00 target price on shares of Liquidia in a research report on Friday. Finally, Jefferies Financial Group restated a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $55.63.

Insider Buying and Selling at Liquidia

In related news, Director Arthur S. Kirsch sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $54.80, for a total transaction of $548,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Roger Jeffs sold 6,428 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $62.18, for a total transaction of $399,693.04. Following the sale, the chief executive officer owned 1,041,667 shares of the company’s stock, valued at $64,770,854.06. The trade was a 0.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,163,911 shares of company stock valued at $53,115,021. 25.60% of the stock is currently owned by corporate insiders.

Liquidia Trading Down 1.1%

Liquidia stock opened at $61.85 on Friday. The firm has a 50 day simple moving average of $46.78 and a 200-day simple moving average of $39.56. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The stock has a market capitalization of $5.50 billion, a PE ratio of 441.82 and a beta of 0.58. Liquidia Corporation has a 12-month low of $11.85 and a 12-month high of $66.24.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. Liquidia’s revenue for the quarter was up 4187.1% compared to the same quarter last year. As a group, equities research analysts expect that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).